Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Neumora Therapeutics Inc’s current trading price is -91.51% away from its 52-week high, while its distance from the 52-week low is 138.95%. The stock’s price range during this period has varied between $0.61 and $17.19. The company, active in the Healthcare sector, saw a trading volume of around 0.8 million for the day, considerably lower average daily volume of 1.51 million observed over the last three months.
Neumora Therapeutics Inc (NMRA) currently has a stock price of $1.46. The stock saw a sharp increase in the last trading session, hitting a high of $18.0 after opening at $1.46. The lowest recorded price for the day was $1.32 before it closed at $1.65.
Neumora Therapeutics Inc’s stock has had a tumultuous market performance.
How Financial Performance Impacts Market Capitalization
Neumora Therapeutics Inc (NMRA) has experienced a quarterly rise of 128.63% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 236.44M and boasts a workforce of 110 employees.
Decoding Analysts’ Ratings for Neumora Therapeutics Inc
As of right now, 1 analyst is rating Neumora Therapeutics Inc as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 5 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.0188, with a change in price of +0.2700. Similarly, Neumora Therapeutics Inc recorded 1,325,576 in trading volume during the last 100 days, posting a change of +22.69%.
How NMRA’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for NMRA stands at 0.11. Similarly, the long-term debt-to-equity ratio is also 0.11.
NMRA Stock Stochastic Average
As of today, the raw stochastic average of Neumora Therapeutics Inc over the past 50 days is 35.65%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 18.71%. Additionally, the Stochastic %K and %D values for the company were 28.43% and 33.51%, respectively, over the past 20 days.
NMRA Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -87.82%.However, over the last six months, we can see a stronger performance of -25.13%. Over the last 30 days, the price of NMRA has fallen by 37.74%. And in the last five days, it has fallen by -6.41%.
